Serologic Surveillance of Anthrax in the Serengeti Ecosystem, Tanzania, 1996–2009
Tiziana Lembo, Katie Hampson , Harriet Auty, Cari A. Beesley, Paul Bessell, Craig Packer, Jo Halliday, Robert Fyumagwa, Richard Hoare, Eblate Ernest, Christine Mentzel, Titus Mlengeya, Karen Stamey, Patricia P. Wilkins, and Sarah Cleaveland
Author affiliations: Author affiliations: University of Glasgow, Glasgow, Scotland (T. Lembo, K. Hampson, H. Auty, P. Bessell, S. Cleaveland); Lincoln Park Zoo, Chicago, Illinois, USA (T. Lembo); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.A. Beesley, K. Stamey, P.P. Wilkins); University of Minnesota, St. Paul, Minnesota, USA (C. Packer); University of Edinburgh, Edinburgh, Scotland (J. Halliday); Tanzania Wildlife Research Institute, Arusha, Tanzania (R. Fyumagwa, R. Hoare, E. Ernest); Endangered Wildlife Trust, Parkview, South Africa (C. Mentzel); Tanzania National Parks, Arusha (T. Mlengeya)
Figure 3. Seroprevalence of anthrax in sampled wildlife populations from Serengeti National Park (white bars) and Ngorongoro Crater (gray bars), Tanzania, 1996–2009. Error bars indicate 95% confidence intervals. Sample sizes used to calculate seroprevalence are indicated above the bars. Hyenas were not sampled in Ngorongoro Crater. Seropositive zebras were not detected; error bars indicate 95% confidence intervals based on a binomial distribution of the sample size and the seropositivity range that can be expected.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.